Latest Strategy News

Vonex Limited reported a significant reduction in net loss alongside operational improvements and a strengthened balance sheet, while advancing a major acquisition scheme with MaxoTel.

Nine Entertainment reported a solid FY25 with $2.7 billion revenue and $133 million net profit, driven by streaming and digital subscriptions, while crystallising value through a $1.4 billion Domain stake sale.

Nine Entertainment Co. Holdings Limited reported a modest dip in FY25 net profit to $133.3 million amid rising costs, while announcing a substantial special dividend tied to the imminent sale of its Domain stake.

Lovisa Holdings delivered a robust FY25 with 14.2% sales growth, margin expansion, and over 160 new stores globally, setting a confident tone for FY26.

Australian Finance Group (AFG) reported a robust FY25 with record broker recruitment, loan book growth, and earnings, driven by technology adoption and diversified products. The company signals a positive outlook for FY26 amid expected cash rate cuts and market momentum.

Lovisa Holdings has reported a robust FY25 with revenue climbing 14.2% and over 160 new stores opened worldwide, signaling strong momentum in the fashion jewellery sector.

Lovisa Holdings Limited reported a 14.2% revenue increase to A$798.1 million for FY25, driven by a net addition of 131 stores globally. Profit after tax rose 4.8% to A$86.3 million, while the company declared a final unfranked dividend of 27 cents per share.

ARN Media reports a 7% revenue decline in H1 2025 amid a strategic transformation, with digital audio growth offsetting radio setbacks and key divestments underway.

Mastermyne Group Limited reported a tough FY2025 with significant revenue and profit declines due to external disruptions, yet strengthened its order book and cash position, positioning itself for future growth.

Wisr Limited has reported a remarkable 101% growth in loan originations for FY25, surpassing its guidance and returning to EBITDA profitability. The fintech lender also secured a $267 million funding facility with Barclays, positioning itself for continued expansion in FY26.

Apiam Animal Health posted modest FY25 revenue growth but saw net profit plunge due to asset impairments, while receiving a non-binding acquisition proposal from Adamantem Capital.

Apiam Animal Health reported modest revenue growth but a sharp net profit decline in FY25, launching a Strategic Reset program under new leadership. The company also received a $0.88 per share acquisition proposal from Adamantem Capital Management.